FIRST AMENDMENT TO SUBLEASESublease • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research
THIS FIRST AMENDMENT TO SUBLEASE (this "First Amendment") is made as of October 1, 2013 (the “Effective Date”), by and between EXELIXIS, INC., a Delaware corporation ("Sublandlord"), and THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation ("Subtenant").
PARTIAL LEASE TERMINATION AGREEMENTPartial Lease Termination Agreement • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research • California
THIS PARTIAL LEASE TERMINATION AGREEMENT (this “Agreement”) is entered into as of June 30, 2015, by and between BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and EXELIXIS, INC., a Delaware corporation (“Tenant”).
SECOND AMENDMENT TO SUBLEASESublease • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research
THIS SECOND AMENDMENT TO SUBLEASE (this “Second Amendment”) is made as of July 1, 2015 (the “Effective Date”), by and between EXELIXIS, INC., a Delaware corporation (“Sublandlord”), and NODALITY, INC., a Delaware corporation (“Subtenant”).
TERMINATION AGREEMENTTermination Agreement • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research • New York
This termination agreement (this “Termination Agreement”) dated December 23, 2014 (the “Signing Date”) is effective as of July 17, 2014 (the “Termination Date”) by and between EXELIXIS, INC., a Delaware corporation located at 210 East Grand Avenue, South San Francisco, California 94080 (“Exelixis”), and GLAXOSMITHKLINE, LLC, a Delaware corporation and successor to SMITHKLINE BEECHAM CORPORATION, located at 5 Crescent Drive, Philadelphia, PA 19112 (“GSK”). Exelixis and GSK are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
FIRST AMENDMENT TO CONSENT TO SUBLEASE AGREEMENTSublease Agreement • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research • California
THIS FIRST AMENDMENT TO CONSENT TO SUBLEASE AGREEMENT (this "First Amendment") is made as of July 1, 2015, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and NODALITY, INC., a Delaware corporation ("Subtenant").
SECOND AMENDMENT TO CONSENT TO SUBLEASE AGREEMENTSublease Agreement • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research • California
THIS SECOND AMENDMENT TO CONSENT TO SUBLEASE AGREEMENT (this "Second Amendment") is made as of July 1, 2015, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation ("Subtenant").
SECOND AMENDMENT TO SUBLEASESublease • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research
THIS SECOND AMENDMENT TO SUBLEASE (this “Second Amendment”) is made as of July 1, 2015 (the “Effective Date”), by and between EXELIXIS, INC., a Delaware corporation (“Sublandlord”), and THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation (“Subtenant”).
FIRST AMENDMENT TO CONSENT TO SUBLEASE AGREEMENTSublease Agreement • August 11th, 2015 • Exelixis, Inc. • Services-commercial physical & biological research • California
THIS FIRST AMENDMENT TO CONSENT TO SUBLEASE AGREEMENT (this "First Amendment") is made as of October 1, 2013, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation ("Subtenant").
